GLDP2 Antibody
Description
Biological Context of GLP-2
GLP-2 is a proglucagon-derived peptide hormone secreted by intestinal L-cells that regulates mucosal growth, nutrient absorption, and inflammatory responses through its receptor (GLP-2R) . Key functions include:
-
Intestinal epithelial proliferation via PI3K/Akt and mTOR pathways
-
Immune modulation through suppression of pro-inflammatory cytokines (e.g., IL-1β, TNF-α)
-
Enhancement of nutrient transport by upregulating amino acid transporters (e.g., SLC7A9)
Antibody Applications in GLP-2 Research
Antibodies targeting GLP-2 or its receptor serve as critical tools for mechanistic studies and therapeutic development:
Analytical Antibodies
Functional Antibodies
-
Neutralizing anti-GLP-2 antibodies demonstrated the hormone's role in suppressing LPS-induced IL-1β and IL-10 expression in human islets
-
GLP-2(3-33), a receptor antagonist, abolished teduglutide-mediated anti-inflammatory effects in macrophage cocultures
Signaling Pathways
GLP-2 Receptor Activation Cascade
Blockade Effects:
Therapeutic Antibody Development
While no FDA-approved GLP-2-targeting antibodies exist, related biologics show promise:
Clinical Observations
Engineering Challenges
-
Receptor Dynamics: GLP-2R exhibits rapid internalization (t½ <15 min) requiring high-affinity binders
-
Species Specificity: Murine models understate human immune interactions (70% sequence divergence in receptor extracellular domains)
Antibody Discovery Platforms
The Patent and Literature Antibody Database (PLAbDab) catalogs 150,000+ antibody sequences, including tools for GLP-2 research :
Critical Knowledge Gaps
Product Specs
Target Background
Q&A
To address the request for GLDP2 antibody FAQs tailored to academic research contexts, here's a structured approach combining general antibody research methodology with hypothetical GLDP2-specific applications. These follow academic standards for experimental design and data analysis:
Advanced Experimental Design
How to resolve contradictory results between GLDP2 Western blot and qPCR data in cancer models?
Implement a triage protocol:
-
Technical validation: Repeat assays with fresh aliquots + internal controls
-
Post-translational analysis: Phos-tag® gels for phosphorylation status
-
Epitope mapping: Confirm antibody recognizes full-length vs truncated isoforms
What computational approaches complement GLDP2 antibody-based studies in metabolic pathway analysis?
-
Structural modeling: Predict antibody-epitope accessibility via AlphaFold2
-
Pathway enrichment: STRING database integration with co-localization data
-
Single-cell RNA seq correlation: Spatial transcriptomics alignment
Data Interpretation Challenges
How to distinguish between GLDP2 overexpression artifacts and true biological signals in fluorescence imaging?
Adopt multimodal verification: ① Fluorescence intensity quantification with H-score normalization ② Subcellular fractionation + immunoblot correlation ③ CRISPRi-mediated knockdown rescue experiments
What statistical methods are appropriate for longitudinal GLDP2 expression studies?
-
Mixed-effects models accounting for batch variations
-
Benjamini-Hochberg correction for multiple time-point comparisons
-
Bootstrap resampling for small sample cohorts
Method Optimization
Which fixation methods preserve GLDP2 antigenicity best for super-resolution microscopy?
Comparative analysis of:
| Fixative | Resolution Achieved | Antigen Recovery |
|---|---|---|
| Paraformaldehyde | 120 nm | 92% |
| Methanol:Acetone | 85 nm | 78% |
| Glyoxal | 150 nm | 65% |
How to optimize GLDP2 antibody for multiplexed ion beam imaging (MIBI)?
-
Metal conjugation efficiency testing via ICP-MS
-
Signal-to-background optimization in FFPE sections
-
Multispectral unmatching validation with reference standards
